Galapagos NV ADR (GLPG) Stock Analysis

Galapagos NV ADR (GLPG) is a publicly traded company in the HEALTHCARE sector. It trades at $27.73. This page summarizes the public market data, fundamentals, and frequently asked questions for GLPG, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $27.73

Market Sentiment

Galapagos NV ADR currently has a Neutral sentiment score of 0.10.

About Galapagos NV ADR

Galapagos NV (Ticker: GLPG) is a clinical-stage biotechnology firm based in Mechelen, Belgium, focused on discovering and developing innovative small molecule medicines for severe diseases with high unmet medical needs. The company has a robust pipeline of drug candidates, leveraging its proprietary drug discovery platform and expertise in various therapeutic areas, including immunology and inflammation. Galapagos collaborates with leading pharmaceutical companies to enhance its research capa...

GNG Research Analysis

GNG Research scores Galapagos NV ADR (GLPG) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GLPG.

Frequently Asked Questions

Does GLPG pay dividends?

Galapagos NV ADR (GLPG) does not currently pay a regular dividend.